Physician profile
Holly C Shaffer
NPI 1952594178
$537.74
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $511 · 2020: $13.06 · 2022: $13.80.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $138.72 | 2019-2022 | |
| Genzyme Corporation | $88.55 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $57.16 | 2019 | |
| Genentech USA, INC. | $39.55 | 2019 | |
| Pfizer INC. | $38.05 | 2019-2020 | |
| Lilly USA, LLC | $28.27 | 2019 | |
| Janssen Biotech, INC. | $23.18 | 2019 | |
| Prugen, INC. Pharmaceuticals | $17.42 | 2019 | |
| Sun Pharmaceutical Industries INC. | $16.95 | 2019 | |
| Pierre Fabre Pharmaceuticals, INC. | $16.52 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $15.81 | 2019 | |
| Biofrontera INC. | $15.28 | 2019 | |
| Ucb, INC. | $15.02 | 2019 | |
| Novartis Pharmaceuticals Corporation | $14.49 | 2019 | |
| Almirall LLC | $12.77 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Holly Shaffer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.